Filters

480 Results

relevance


Curaleaf

Ad Alert

Curaleaf

FDA warning letter sparks changes to company’s marketing of CBD products.

Primerica

Ad Alert

Primerica

TINA.org breaks down deceptive income claims touted by top earner at recent convention.

Comment at FDA Public Meeting on Dietary Supplements

Blog

Comment at FDA Public Meeting on Dietary Supplements

Comment made by TINA.org executive director, Bonnie Patten at the FDA’s public meeting on Responsible Innovation in Dietary Supplements held on May 16, 2019. Thank you for the opportunity to…

Show More